What is Michael Yoo arguing about federal IDR?

Dr. Michael Yoo argues that efforts to weaken federal IDR threaten physician payment, practice viability, and ultimately patient access. That is an advocacy position. The official record confirms that IDR resolves eligible out-of-network payment disputes, but it does not by itself establish every claimed market effect or motive.

Is federal IDR available for every underpaid medical claim?

No. Federal IDR is available only for qualifying out-of-network items and services when the applicable federal requirements are met, including an unsuccessful 30-business-day open-negotiation period. State law or another dispute route may govern other claims.

What do the latest CMS IDR results show?

CMS reported that providers, facilities, and air ambulance providers prevailed in approximately 88 percent of payment determinations in the first half of 2025. CMS also reported that 22 percent of determinations were defaults. Those figures show a recurring gap between payer and provider positions, but they do not identify the cause of every dispute.

What should providers preserve for an IDR policy or payment dispute?

Providers should preserve the claim, initial payment or denial, line-level QPA, required disclosures, open-negotiation notices, final offers, eligibility communications, IDR determination, payment record, and every deadline.

Federal IDR, Physician Access & Payment

Direct answer

What is Dr. Michael Yoo arguing about federal IDR?

Dr. Michael Yoo argues that efforts to weaken the federal independent dispute resolution process could reduce physicians' ability to challenge insurer payments, pressure independent practices, and eventually limit patient access. His October 25 LinkedIn post frames the current policy debate as a fight over whether physicians retain a neutral payment-dispute forum after patients are removed from the middle.

The post advances an advocacy argument rather than a neutral empirical study or causal analysis. Its central policy question is still important: if federal IDR is changed, what happens to initial payments, physician participation, network negotiations, and access to specialty care?

What does federal IDR actually do?

The No Surprises Act generally protects patients from certain out-of-network balance bills. For qualifying items and services, the provider or facility and the health plan resolve the out-of-network payment without placing the patient in the payment dispute.

Federal IDR is not available for every claim. It applies only when the item or service, coverage, parties, and jurisdiction satisfy the federal requirements. The parties first complete a 30-business-day open negotiation. If they do not agree, either party may initiate federal IDR within the applicable deadline and a certified IDR entity selects one of the submitted offers.

That structure matters. Patient protection and provider payment are separate parts of the same statutory design. Preserving the first while removing or materially weakening the second would change the bargain Congress enacted.

What do the latest official IDR results show?

The Departments reported that providers, facilities, and air ambulance providers were the prevailing party in approximately 88% of payment determinations made during the first six months of 2025. The prevailing offer was also higher than the qualifying payment amount in approximately 88% of determinations.

The same report says 22% of payment determinations were default decisions. A default can occur when one party fails to submit an offer or pay its fee and the other party completes those steps. The Departments separately reported an 87% provider-side win rate among non-default decisions during that period.

Those results show a persistent divide between payer and provider positions. They do not prove a coordinated motive, establish that every initial payment was inadequate, or resolve whether every prevailing offer reflected the correct out-of-network rate. The data should prompt claim-level analysis rather than a slogan from either side.

Halkovich Law's commentary

Dr. Yoo is right to connect reimbursement policy with the real-world supply of medical care. Payment rules affect staffing, call coverage, network participation, capital decisions, and whether an independent practice can continue operating. Policymakers should test proposed IDR changes against those consequences instead of treating arbitration as a closed accounting exercise.

The most persuasive case for preserving IDR does not require assuming that every provider offer is correct. Neutral review has value precisely because the parties disagree. Meaningful reform should improve eligibility decisions, QPA transparency, administrative speed, participation by both sides, and timely payment of final awards. It should not return unilateral pricing authority to either party.

Dr. Yoo also speaks directly to in-network physicians. Those physicians generally cannot use federal IDR for contracted claims, but out-of-network benchmarks and dispute outcomes may influence contract negotiations and payer expectations across the market. That broader effect is plausible and deserves study. It should be measured through network participation, contract rates, specialist availability, patient wait times, and practice closures rather than asserted as a foregone conclusion.

What evidence should Congress and regulators require?

Initial payments and final offers by payer, service, geography, specialty, and claim value.
QPA calculation and disclosure compliance, including corrected benchmarks and affected claims.
Defaults, nominal offers, eligibility decisions, withdrawals, and time to determination.
Whether final awards were paid in full and within the required period.
Changes in network participation, contracting terms, physician supply, and patient access.
Administrative cost separated from the underlying payment for medical services.

A policy evaluation that counts awards but omits the payments, offers, defaults, and benchmarks that produced them cannot explain why disputes occurred or what reform would improve the system.

What should providers document now?

Preserve the claim, initial payment or denial, remittance advice, line-level QPA, and required disclosures.
Track the open-negotiation notice, delivery confirmation, negotiation record, and every deadline.
Retain both parties' final offers, the certified IDR entity's determination, and the supporting submissions.
Record defaults, eligibility objections, portal notices, administrative fees, and delays.
Reconcile the final award against the actual payment and document any unpaid balance.
Analyze recurring patterns by payer and plan instead of treating each disputed claim as an isolated event.

Good records serve two purposes: they protect the individual dispute and create the evidence needed to evaluate broader payer conduct and policy claims.

Frequently asked questions

Is federal IDR a patient billing process?

No. For eligible No Surprises Act claims, federal IDR determines the out-of-network payment between the provider or facility and the health plan. The patient is protected from being placed in that payment dispute, subject to the law's coverage rules.

Is federal IDR available for every underpaid claim?

No. The claim must qualify under the federal statute and rules, the parties must complete open negotiation, and the dispute must be initiated on time. State law, contract remedies, ERISA, or another process may govern other claims.

Does the provider win rate prove every initial payment was too low?

No. The approximately 88% provider-side prevailing rate in the first half of 2025 is important evidence of recurring disagreement, but it does not identify the cause of every dispute. Defaults, offers, claim facts, QPAs, and the certified IDR entity's record matter.

Why can IDR policy matter to in-network physicians?

In-network claims are generally governed by contracts rather than federal IDR. Out-of-network benchmarks and dispute outcomes may still affect payer negotiating positions and what the market treats as a reasonable rate. Measuring that effect requires network and access data.

Sources and scope

This article is Halkovich Law's original provider-side commentary on a LinkedIn post by Dr. Michael Yoo. His statements about carrier strategy, physician practice viability, and patient access are identified as advocacy and should not be read as findings by CMS. Official process and outcome figures are drawn from the linked federal sources.

The page provides general information, not claim-specific legal advice. Federal IDR eligibility and deadlines depend on the service, plan, jurisdiction, notices, and procedural record.

Why Federal IDR Matters for Physician Payment and Patient Access